Multiple Sclerosis (MS) is a devastating autoimmune disease that result from the immune system attacking parts of the nervous system. For a long time, MS has been treated with broad immunosuppression using corticosteroids that puts the patient at risk for infections, but this might soon change. In today's Beyond the Abstract episode, Derek and Dan talk about a new paper that uses a novel mRNA vaccine to prevent and even treat MS, brought to you in part by BioNTech (the same company that helped develop the COVID-19 vaccine). Krienke et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science, January 2021. DOI: 10.1126/science.aay3638 The information presented here is not medical advice. Consult your physician on any questions regarding your personal health.